Ovarian cancer patients frequently exhibit evidence of immunogenic tumour recognition, such as CD8+ T cell tumour infiltration; however immunosuppression within the TME frequently prevents their effector function [57, 109]. This evidence concerns the gene CD8A and ovarian carcinoma.